About Actorius
Actorius is a Healthcare company based in Simi Valley (United States) founded in 2013 by Aravindan Vasudevan and Murlidhara Padigaru. Genomics-based diagnostic tests for cancer are developed. Actorius has raised $1.27 million across 6 funding rounds from investors including Vision Biosciences, Raj Rajeshwar Projects and Swati Khandare. Its chief executive, as recorded, is Aravindan Vasudevan. Its Indian entity Actorius Innovations And Research Private Limited reported revenue of ₹1.47 Cr. Actorius offers products and services including OncoDiscover Liquid Biopsy Test. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its competitors include Guardant Health, Natera and Foundation Medicine; 3 of its 3 listed competitors have raised funding.
Company details
Actorius was founded in 2013 in Simi Valley, United States, within the biotechnology sector focused on oncology. Genomics-based tools for cancer diagnostics are provided, including OncoDiscover Liquid Biopsy for detecting and enumerating circulating tumor cells from low blood volumes. OncoDialysis is utilized for removing these cells, and drug formulations for cancer treatment are developed. Operations center on advancing precision medicine through these technologies.
- Headquarters Simi Valley, United States
- Founders Aravindan Vasudevan, Murlidhara Padigaru
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website actorius.co
- Social LinkedIn X YouTube
- Legal Name Actorius Innovations And Research Private Limited
- Date of Incorporation 14 Aug, 2013
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹1.47 Cr
FY 2024 · -15% YoY
- Indian entity net loss-₹2.00 Cr
FY 2024 · -135% margin
- Indian entity EBITDA-₹1.62 Cr
FY 2024 · -110% margin
- Total Equity Funding$1.27M (USD)
in 6 rounds
- Latest Funding Round$295.93K (USD), Seed
Nov 2024
- InvestorsVision Biosciences
& 12 more
Associated legal entities of Actorius
Actorius operates through Actorius Innovations And Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Actorius Innovations And Research Private Limited CIN U73100MH2013PTC246961 | Active | 14 Aug 2013 | Mumbai, Maharashtra | ₹1.5 Cr | 3 | View details |
Products & Services of Actorius
Actorius offers a comprehensive portfolio of products and services, including OncoDiscover Liquid Biopsy Test.
Detects circulating tumor cells for cancer monitoring using minimal blood.
Apps and channels of Actorius
its YouTube channel Onco Discover has 18 subscribers and 2 videos.
Videos from Actorius
The most watched videos on Actorius's YouTube channel, Onco Discover (18 subscribers). Click a video to play it here.
More on Onco Discover.
Funding Insights of Actorius
Actorius has successfully raised a total of $1.27M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $295.93 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.27M
- Total Rounds 6
- Last Round Seed — $295,928
- First Round $164,086
(Dec 2020)
- Investors Count 13
All 6 funding rounds of Actorius with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $295,928 | Seed | – | – | |
| May 2024 | $60,355 | Angel Round | – | – | |
| Sep 2023 | $241,766 | Angel Round | – | – | |
| Nov 2022 | $241,984 | Seed | – | – | |
| Oct 2021 | $266,762 | Seed | – | – | |
| Dec 2020 | $164,086 | Seed | – | – |
12 investors in total: 3 institutional and 9 angel.
Investors in Actorius
Actorius has secured backing from 12 investors, including institutional and angel investors. Prominent investors backing the company include Vision Biosciences, Raj Rajeshwar Projects and Swati Khandare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
SK Swati Khandare | unknown_7b66d4cd174046819 | |||
MM Manoj Mathew | unknown_e5c07e60e3ea4e46a | |||
SB Sanjay Boldane | unknown_50e26cd323ee4bf68 | |||
SK Sachin Kulkarni | unknown_9fcdef5f2ba049ad8 | |||
JS Jitendra Sahastrabudha | unknown_20969c6324e44b878 | |||
MU Mohan Uttarwar | unknown_58fd044ab1974ef49 | |||
VK Vandana Karale | unknown_c356c7fd53c743e99 | |||
AB Asraf Baig | unknown_1c40c367dd9a4616a | |||
MM Manish Mutha | unknown_0fd6f8eba57549999 |
Investor details for Actorius
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Actorius Innovations And Research Private Limited (Actorius)
Actorius Innovations And Research Private Limited is the primary company behind Actorius. The board of Actorius Innovations And Research Private Limited currently have 3 directors; the longest-serving is Jayant Jagannath Khandare, appointed in 2013. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jayant Jagannath Khandare DIN 06585502 | Director | 14 Aug 2013 | 13 yrs 2 mo | Actorius Innovations And Research Private Limited |
| Aravindan Vasudevan DIN 06584696 | Director | 14 Aug 2013 | 13 yrs 2 mo | Actorius Innovations And Research Private Limited |
| Rakshit Shriram Kamble DIN 08875299 | Director | 15 Sep 2020 | 6 yrs 1 mo | Actorius Innovations And Research Private Limited |
People of Actorius
3 people are tracked at Actorius (3 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & Co-CEO | Leadership | |
| Co-Founder | Leadership | |
Rick Kamble | Co-CEO | Leadership |
Complete people profiles for Actorius
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Actorius
Figures of Actorius Innovations And Research Private Limited, the primary company behind Actorius, for FY 2024. Revenue was ₹1.47 Cr (-15% year on year). Net loss was -₹2.00 Cr (-135% margin). EBITDA was -₹1.62 Cr (-110% margin). Revenue has grown at a compounded annual rate of +1% over three years and +159% over five years.
- ₹1.47 CrRevenue · FY 2024 · -15% YoY
- -₹2.00 CrNet loss · -135% margin
- -₹1.62 CrEBITDA · -110% margin
- ₹1.6 LakhPaid-up capital
- +1%Revenue CAGR, 3 years
- +159%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Actorius Innovations And Research Private Limited are on its company page.
Detailed financial statements for Actorius
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Actorius
3 dated milestones of Actorius across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Actorius is founded.
- Funding First funding round of $164K.
- Funding Latest funding round, Seed, of $296K.
Competitors of Actorius
Actorius has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, Natera and Foundation Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. |
Detailed competitors of Actorius
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Actorius (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Actorius
Actorius was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Actorius is headquartered in Simi Valley, United States. It is registered at Simi Valley, California, United States.
Aravindan Vasudevan is the CEO of Actorius, as recorded in our data. They have also founded this company.
Actorius is a funded company, having raised a total of $1.27M across 6 funding rounds to date. The company's 1st funding round was a Seed of $164.09K, raised on Dec 2020.
The primary company behind Actorius, Actorius Innovations And Research Private Limited, reported revenue of ₹1.47 Cr for FY 2024, down 15% year on year.
Actorius was founded in 2013 in Simi Valley, United States, within the biotechnology sector focused on oncology. Genomics-based tools for cancer diagnostics are provided, including OncoDiscover Liquid Biopsy for detecting and enumerating circulating tumor cells from low blood volumes. OncoDialysis is utilized for removing these cells, and drug formulations for cancer treatment are developed. Operations center on advancing precision medicine through these technologies.
Actorius's top competitors include Guardant Health, Foundation Medicine and Natera.
Actorius offers OncoDiscover Liquid Biopsy Test.
Actorius has 12 investors. Key investors include Vision Biosciences, Raj Rajeshwar Projects, Swati Khandare, Manoj Mathew, and Intreden Exim Private Limited.
Actorius operates through Actorius Innovations And Research Private Limited.
The legal entities of Actorius currently have 3 directors, including Rakshit Shriram Kamble, Jayant Jagannath Khandare, Aravindan Vasudevan.